Using genomics to understand antimicrobial resistance and transmission in neisseria gonorrhoeae

12Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

Abstract

Gonorrhoea infections are on the increase and strains that are resistant to all antimicrobials used to treat the disease have been found worldwide. These observations encouraged the World Health Organization to include Neisseria gonorrhoeae on their list of high-priority organisms in need of new treatments. Fortunately, concurrent resistance to both antimicrobials used in dual therapy is still rare. The fight against antimicrobial resistance (AMR) must begin from an understanding of how it evolves and spreads in sexual networks. Genome-based analyses have allowed the study of the gonococcal population dynamics and transmission, giving a novel perspective on AMR gonorrhoea. Here, we will review past, present and future treatment options for gonorrhoea and explain how genomics is helping to increase our understanding of the changing AMR and transmission landscape. This article contains data hosted by Microreact.

Cite

CITATION STYLE

APA

Sanchez-Busó, L., & Harris, S. R. (2019, February 1). Using genomics to understand antimicrobial resistance and transmission in neisseria gonorrhoeae. Microbial Genomics. Microbiology Society. https://doi.org/10.1099/mgen.0.000239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free